Further delay to revised EU Tobacco Products Directive 'will raise serious questions about whose interest the EU Commission is promoting'

October 25, 2012

A Lancet News podcast special report also looks at these issues, featuring interviews with John Dalli, who recently resigned his post of EU Commissioner for Health and Consumer Policy.

Dalli's controversial resignation, as a result of allegations of financial impropriety involving tobacco companies, has led to the revised Tobacco Directive being put on hold, despite the fact that the text has been cleared, administratively and legally, to progress to the next stage of implementation.

Just two days after Mr Dalli's resignation, the offices of anti-tobacco campaigners in Brussels appear to have been subject to a sophisticated burglary, in which laptops and documents were stolen, but other valuables left untouched.

According to Professor Martin McKee, Professor of European Public Health at the London School of Hygiene and Tropical Medicine, and one of the authors of the Comment, these events have "set alarm bells ringing."

"While the truth about these events will emerge eventually, it may be too late for the revised Tobacco Products Directive. Yet there is no reason why this should be so. The only beneficiaries of delay are the tobacco companies," says Professor McKee.

Comment co-author Paul Belcher, Senior EU Government Affairs Advisor at the Royal College of Physicians in London, adds, "The current situation is undermining both citizens' confidence in EU decision making as well as public health efforts to combat the scourge of tobacco."*

In an interview with The Lancet News podcast, former Commissioner Dalli describes the circumstances of his resignation: "I was called to a meeting for which I had no agenda, then I was confronted immediately...'listen, we have this report, [containing] these allegations, and you have to go. You can resign, or I can fire you.'... I resisted the question of resignation. I said, first of all, I don't know exactly what the basis of this message is. Secondly, I did not do anything wrong...I asked for some time to consult lawyers...I asked for 24 hours, also to inform my family, and I was given thirty minutes."

When asked about the safeguards that are in place to prevent any weakening of the Directive now that progress has stalled, Mr Dalli told The Lancet News podcast that "The safeguard was me."

Monika Kosinska, Secretary General of the European Public Health Alliance, one of the organisations whose offices were burgled in Brussels, and a co-author of The Lancet Comment, also spoke to The Lancet News podcast, describing the delays to the revised Tobacco Products Directive as "paralysing", and speculating that "there's no reason to immediately think that everyone in the commission is going to be behind the Tobacco Products Directive."
-end-
NOTES TO EDITORS:

*Quote direct from author and cannot be found in text of Comment.

Lancet

Related Tobacco Articles from Brightsurf:

UC studies tobacco use, cancer connection
Researchers at the University of Cincinnati have identified new clues into ways tobacco use impacts patients with kidney cancer.

'Best' hospitals should be required to deliver tobacco treatment
A UCLA-led report published today in the Journal of the American Medical Association Internal Medicine exposes what the authors call a weakness in the high-profile 'Best Hospitals Honor Roll' published annually by US News and World Report.

Small shops, heavy advertisers less likely to ID for tobacco
'Our findings suggest that certain types of stores -- tobacco shops, convenience stores and those with a lot of tobacco advertising -- are more likely to sell tobacco to a young person without checking his or her ID.'

Youth smoking and vaping: What does it mean for tobacco control
New research from PIRE/PRC features analysis of in-depth, qualitative interviews with young vapers in California between 15 and 25.

Truth telling about tobacco and nicotine
In 'Truth Telling about Tobacco and Nicotine,' PRC researchers explain that, although there is agreement among researchers about evidence that vaping can be less harmful than combustible cigarettes, the tobacco control community remains divided about how to communicate -- or even whether to communicate -- information about the relative risks of tobacco and nicotine products.

A 'joint' problem: Investigating marijuana and tobacco co-use
A survey of marijuana and tobacco co-users by Medical University of South Carolina investigators found that co-users with high degree of interrelatedness between their use of the two substances had greater tobacco dependence and smoked more cigarettes per day.

How genes affect tobacco and alcohol use
A new study gives insight into the complexity of genetic and environmental factors that compel some of us to drink and smoke more than others.

Tobacco use linked with higher use of opioids and sedatives
Tobacco is a known risk factor for the misuse of prescription opioids.

Changes in flavored tobacco product use among youth tobacco users
Self-reportedĀ use of flavored tobacco products by middle and high school students decreased from 2014 to 2016 but climbed back up in 2017 in an analysis of national survey data.

Heated tobacco product claims by tobacco industry scrutinized by UCSF researchers
Claims by the tobacco industry that heated tobacco products (HTPs) are safer than conventional cigarettes are not supported by the industry's own data and are likely to be misunderstood by consumers, according to research published in a special issue of Tobacco Control.

Read More: Tobacco News and Tobacco Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.